哪些患者应该考虑在新辅助化疗完全缓解后进行膀胱保留治疗。
Which Patients To Consider for Bladder Preservation After a Complete Response to Neoadjuvant Chemotherapy.
发表日期：2023 Feb 10
作者：
Martin Egger, Roland Seiler
来源：
European Urology Focus
摘要：
对于哪些患有肌层侵犯性膀胱癌的患者应该考虑保留膀胱的决定仍然存在争议。未来新的有前途的技术和生物标志物可能会允许精确选择保留膀胱的患者。目前，在高度选择的情况下和在临床试验的背景下才应考虑保留膀胱。版权所有©2023欧洲泌尿协会。由Elsevier B.V.出版。保留所有权利。
The decision on which patients with muscle-invasive bladder cancer to consider for bladder preservation remains controversial. New promising technologies and biomarkers may allow to precise selection of patients for bladder preservation in the future. Currently, bladder preservation should only be considered in highly selected cases and in the setting of clinical trials.Copyright © 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.